From molecular fingerprinting of the tumour to a personalised treatment strategy

A combination of different molecular techniques is key to reach clinical benefit

Scroll down to discover

What is the current situation in oncology practice?

We have developed solutions especially designed for your needs

Screening more than the usual suspects

We have developed a unique and powerful combination of biomarker tests to support your therapeutic decision-making: next-generation sequencing of large gene panels, immunohistochemistry analysis and other tests performed on both solid and/or liquid biopsies.

 

Solid Biopsy profiling

Our first solution combining DNA, RNA and protein analyses of a tissue biopsy.

Solid & Liquid biopsy Profiling

A complete solution integrating the analysis of solid and liquid biopsies.

Liquid Biopsy Profiling

Next-generation sequencing of smart panels with selected key genes per tumor type from a blood sample.

Liquid Biopsy Profiling

The first personalised liquid biopsy in the market.

From molecular complexity to clear decisions

OncoKDM is an online platform that turns your NGS data into actionable clinical information. Moreover, OncoKDM can integrate NGS results with IHC, MSI and TMB data. The resulting comprehensive and interactive report includes updated information about approved and investigational treatments for each patient, as well as NGS quality control data, patient clinical data and comprehensive NGS variants annotation.

Our platform OncoSHARE shows you the results of your patient's molecular profiling through an online integrated theranostic report that includes a comprehensive biological and clinical interpretation. This report gives you an insight into the most effective treatments according to the unique features of your patient's tumour, taking into account the most relevant scientific information, official cancer guidelines and recruiting clinical trials.

Knowledge-Driven Medicine

Transforming cancer data into knowledge-driven medicine

Online interface for reporting the results of our tests

Connecting healthcare professionals and patients

Patient case studies

They trust our expertise

More testimonial videos
Prof. Dr. Jesús García-Foncillas
Professor of Oncology
Hospital Universario Fundación Jiménez Díaz - Spain

Thanks to OncoDEEP, we were able to identify a new treatment that would have not been found from routine testing.

Dr. Jean-Loup Mouysset
Oncologist
Clinique Rambot-Provencale - France

Precision medicine is becoming unavoidable for treating cancer. Each patient is unique, and there is a unique way to take care of him/her.

Keep learning and engage with other experts

At OncoDNA, we believe in collaboration to ensure the delivery of personalised cancer care. Our latest projects include MDIP - the Molecular Diagnostic Innovation Partnership - and ONCOmmunity - the molecular oncology podcast. While MDIP aims to bring together care providers, payors, clinicians, nurses and patients to improve access to biomarker testing collectively; ONCOmmunity explores some aspects of molecular oncology in the treatment of cancer together with experts from various professional backgrounds and horizons.